Stock Evaluator: MediPal Holdings Corporation (MAHLY)
MediPal Holdings Corporation MAHLY
$18.30
0.00
0.00%
July 27, 2026 1:15:39 PM
EST
Volume: 0
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
| DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Health Care Providers & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health products for companion animals; and food processing raw materials for agriculture, fisheries, and livestock. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand; and distributes specialty pharmaceuticals. Further, the company is involved in contract logistics services; information provision services; health insurance claims review, medical coding dispatch, outsourcing and remote education; and creation of a medical supply database and master product databases for medical facilities. It serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fish producers, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
Financial Summary
| Share Statistics | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $3,703.3 | $1,742.7 | 62% |
|
| Shares Out (Mil) | 1.3 | 76.7 | 5% |
|
| Institutional Ownership | 49.8% | 89.7% | 26% |
|
| Float (Mil) | 178.4 | 49.4 | 72% |
|
| Beta | -0.03 | 0.82 | 5% |
|
| Avg Daily Volume (000s) | 1 | 521 | 4% |
|
| Price Change (52-week) |
(3.4%) | 78.7% | 43% |
|
| Growth | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (3.7%) | 11.0% | 10% |
|
| Net Income (5yr) | 4.3% | (0.7%) | 46% |
|
| EPS (5yr) | 6.1% | 3.1% | 40 |
|
| Dividends (5yr) | (14.9%) | 0.0% | 0% |
|
| Cash Flow (5yr) | 11.7% | (18.0%) | 71% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $24,008 | $1,456 | 93% |
|
| Net Income (TTM) (Mil) | $268 | $12 | 72% |
|
| EPS (TTM) | $1.300 | $0.300 | 64% |
|
| Operating Cash Flow (TTM) (Mil) | na | $138 | na |
|
| Net Cash Flow (TTM) (Mil) | na | $8 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $316 | 0% |
|
| Enterprise Value (Q1) (Mil) | $2,691 | $2,170 | 53% |
|
| Valuation | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.85 | na |
|
| P/E | na | 26.7 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | MAHLY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 6.8% | 27.8% | 7% |
|
| Net Margin | 1.1% | 1.1% | 35% |
|
| ROA | 2.2% | 1.8% | 57% |
|
| ROE | 6.6% | 7.1% | 48% |
|
| Liabilities to Assets | 58.6% | 59.9% | 52% |
|
| F-Score | na | 5 | na |
|
MediPal Holdings Corporation did not pass any screens on 7/31/2026.
